The recent findings are suggesting that CaMKII activity, which is another major component of the non-canonical Wnt pathway, constitutes a potential target for neuroprotection after ischemic stroke (Coultrap et al., 2011). This evidence concerns the gene CAMK2G and ischemic stroke.